» Journals » Aging Med (Milton)

Aging Medicine

Aging Medicine is a scientific journal, published since 2018 in English. The journal's country of origin is Australia and its primary focus area is geriatrics.

Details
Abbr. Aging Med (Milton)
Start 2018
End Continuing
Frequency Four issues per year
e-ISSN 2475-0360
Country Australia
Language English
Specialty Geriatrics
Metrics
h-index / Ranks: 13168 16
SJR / Ranks: 7464 604
CiteScore / Ranks: 5824 4.50
Recent Articles
1.
Chauhan S, Jena D, Gaidhane S, Dev N, Bushi G, Priya G, et al.
Aging Med (Milton) . 2025 Feb; 8(1):e70002. PMID: 40017668
Objectives: This study aims to analyze the trends in the burden of Alzheimer's Disease and Other Dementias (ADoD) in South Asia from 1990 to 2021, focusing on incidence, prevalence, mortality,...
2.
Gao J, Yuan Y, Wang X, He L, Li L
Aging Med (Milton) . 2025 Feb; 8(1):e70000. PMID: 40012861
Immune checkpoint inhibitors (ICI), have transformed the management of several types of cancers; however, immune-related adverse events (irAEs) may cause treatment interruptions, chronic toxic effects, and death. Elderly patients are...
3.
Zhang H, Yuan M, Pan Q
Aging Med (Milton) . 2025 Feb; 8(1):e70007. PMID: 39990629
Insulin autoimmune syndrome (IAS) is a rare autoimmune disorder characterized by spontaneous hypoglycemia. The incidence of IAS is higher in East Asian populations compared to other populations. Delayed diagnosis and...
4.
Zou P, Li J, Chen L, Liu M, Nie H, Yan J, et al.
Aging Med (Milton) . 2025 Feb; 8(1):e70005. PMID: 39981292
Objectives: Older individuals usually have greater arterial stiffness, lower serum Klotho levels and a greater incidence of chronic kidney disease (CKD). The current study aimed to evaluate the interaction effect...
5.
Roncal-Belzunce V, Gutierrez-Valencia M, Cedeno-Veloz B, San Miguel R, Marin-Epelde I, Galbete A, et al.
Aging Med (Milton) . 2025 Feb; 8(1):e70001. PMID: 39968007
Objectives: The increase in polypharmacy among older adults increases the risk of drug-related problems, making multidisciplinary interventions essential. This study evaluated the impact of a multidisciplinary polypharmacy consultation on medication...
6.
Xiong Y, Zhu X, Xu H, Zheng Z, Luo Q
Aging Med (Milton) . 2025 Feb; 8(1):e70009. PMID: 39968006
Objectives: Diabetic nephropathy (DN) is a severe complication of diabetes mellitus, and its pathogenesis remains incompletely understood. Emerging evidence suggests a potential link between gut microbiota and DN. This study...
7.
Conic J, Chetty A, Chen L, Marsh A, Barry S, Pattabhi R, et al.
Aging Med (Milton) . 2025 Feb; 8(1):e70004. PMID: 39968005
Objectives: Alzheimer's disease (AD) is a prevalent age-related neurodegenerative disease that affects millions of individuals in the United States. Neuroinflammation is a driver of the neurodegenerative changes that characterize AD,...
8.
Liu X, Zuo L
Aging Med (Milton) . 2025 Feb; 8(1):e12370. PMID: 39949470
Sibeprenlimab is a humanized IgG2 monoclonal antibody that binds to and neutralizes the activity of APRIL. It should usher in a new era in the treatment of IgAN, especially in...
9.
Ghaderi S, Mohammadi S, Fatehi F
Aging Med (Milton) . 2025 Feb; 8(1):e70006. PMID: 39949469
The complex interplay between diamagnetic and paramagnetic substances within the brain, particularly in the context of Alzheimer's disease (AD), offers a rich landscape for investigation using advanced quantitative neuroimaging techniques....
10.
Yin Z, Xie H, Liu F, Kong X, Chen W, Gong Y, et al.
Aging Med (Milton) . 2025 Jan; 7(6):689-698. PMID: 39777104
Objectives: This study aimed to determine whether type 2 diabetes (T2D) is an independent risk factor for sleep disorders in the elderly and explore the possible intestinal flora factors of...